Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psychedelics: Threshold of a Therapeutic Revolution
David J. Heal, Sharon L. Smith, Sean J. Belouin, et al.
Neuropharmacology (2023) Vol. 236, pp. 109610-109610
Open Access | Times Cited: 25

Showing 25 citing articles:

Distinctive But Not Exceptional: The Risks of Psychedelic Ethical Exceptionalism
Katherine Cheung, Brian D. Earp, Kyle Patch, et al.
The American Journal of Bioethics (2025) Vol. 25, Iss. 1, pp. 16-28
Closed Access | Times Cited: 14
The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials
Lavinia Hogea, Dana Cătălina Tabugan, Iuliana Costea, et al.
Medicina (2025) Vol. 61, Iss. 2, pp. 278-278
Open Access | Times Cited: 2
Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy
Erika Belitzky, Leonardo César Carvalho, Melissa V. Taylor, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access
Synthetic surprise as the foundation of the psychedelic experience
Roberto De Filippo, Dietmar Schmitz
Neuroscience & Biobehavioral Reviews (2024) Vol. 157, pp. 105538-105538
Open Access | Times Cited: 4
Psychedelic Therapy: A Primer for Primary Care Clinicians—Historical Perspective and Overview
Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, et al.
American Journal of Therapeutics (2024) Vol. 31, Iss. 2, pp. e97-e103
Closed Access | Times Cited: 4
Need for a Public Health Response to the Unregulated Sales of Amanita muscaria Mushrooms
Eric C. Leas, Nora Satybaldiyeva, Wayne Kepner, et al.
American Journal of Preventive Medicine (2024)
Closed Access | Times Cited: 4
Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity
Daniel A Kinderlehrer
Neuropsychiatric Disease and Treatment (2025) Vol. Volume 21, pp. 141-155
Open Access
Shrinking the know–do gap in psychedelic-assisted therapy
Ginger E. Nicol, Danielle R. Adams, Eric J. Lenze, et al.
Nature Human Behaviour (2025)
Closed Access
The renaissance of psychedelics in modern psychiatry: a new breakthrough or the myth of a “magic bullet”?
Valentin Yurievich Skryabin
Neurology Bulletin (2025) Vol. LVII, Iss. 1, pp. 89-95
Closed Access
Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning‐Based Advanced Perspectives
Sung‐Hyun Kim, Sumin Yang, Jeehye Jung, et al.
Advanced Science (2025)
Open Access
Psychedelics, OCD and related disorders: A systematic review
Marianna Graziosi, J. Rohde, Praachi Tiwari, et al.
Journal of Obsessive-Compulsive and Related Disorders (2024) Vol. 41, pp. 100873-100873
Closed Access | Times Cited: 3
Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder
Sandra Szafoni, Piotr Gręblowski, Klaudia Grabowska, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Psychedelic-Assisted Psychotherapy and Mindfulness-Based Cognitive Therapy: Potential Synergies
Richard Chambers, Devon Stoliker, Otto Simonsson
Mindfulness (2023) Vol. 14, Iss. 9, pp. 2111-2123
Open Access | Times Cited: 6
The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis
Mu‐Hong Chen, Shu-Li Cheng, Yu‐Chen Kao, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1
Association between lifetime hallucinogen use and psychological distress varies by sexual identity in a nationally representative sample
B. M. Altman, Manya Magnus
Journal of Psychopharmacology (2024) Vol. 38, Iss. 10, pp. 861-872
Closed Access | Times Cited: 1
Can research on entactogens contribute to a deeper understanding of human sexuality?
Justyna Holka-Pokorska
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1381-1397
Open Access | Times Cited: 3
Microbiome: The Next Frontier in Psychedelic Renaissance
Robert B. Kargbo
Journal of Xenobiotics (2023) Vol. 13, Iss. 3, pp. 386-401
Open Access | Times Cited: 2
Antidepressant medications have evolved in terms of speed of onset of efficacy: How can we best measure antidepressant treatment response?
Jan Sedway, Mark Opler, Leslie Citrome
Current Medical Research and Opinion (2024) Vol. 40, Iss. 4, pp. 701-703
Open Access
The role of psilocybin in depressive disorders
Jadwiga Najib
Current Medical Research and Opinion (2024) Vol. 40, Iss. 10, pp. 1793-1808
Closed Access
An estimate of the number of people with clinical depression eligible for psilocybin-assisted therapy in the United States
Syed F. Rab, Charles L. Raison, Elliot Marseille
Psychedelics. (2024), pp. 1-5
Closed Access
Psychedelic Research for Alcohol Use Disorder with Comorbid Major Depressive Disorder: An Unmet Need
Daan de Jonge, Pim B. van der Meer, Cornelis Kramers, et al.
Current Psychiatry Reports (2024)
Closed Access
The safety of psilocybin-assisted psychotherapy: A systematic review
Rosana Freitas, Efstathia S Gotsis, Alexander Gallo, et al.
Australian & New Zealand Journal of Psychiatry (2024)
Closed Access
ALSUntangled #77: Psilocybin
Bhavya Bakshi, Sandeep Yerraguntla, Carmel Armon, et al.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2024), pp. 1-4
Closed Access
Women’s Drug Use in Everyday Life
Emma Eleonorasdotter
Springer eBooks (2023)
Closed Access | Times Cited: 1
Is Therapeutic Use of Psychedelic Medication Influenced by Bias?
Geraldine S. Pearson
Journal of the American Psychiatric Nurses Association (2023) Vol. 29, Iss. 5, pp. 361-362
Open Access
Page 1

Scroll to top